Clarity
Do they understand what you do?
15 could name what kind of product this is, unprompted.
https://eli.health/pages/for-organizations15 AI-simulated buyers
Your message needs work: they know what it is, who it's for, and why it's worth their time, but not why to pick you.
Do they understand what you do?
15 could name what kind of product this is, unprompted.
Can they tell what it solves, and who it's for?
15 could quickly tell what problem it solves and who it is for.
Do they actually want it?
10 would take a meeting to learn more.
Is there a reason to pick you over the alternatives?
0 could name a reason to pick you over a similar option.
Your page describes: saliva testing. They said:
5 couldn't name one; 10 got it right.
Four separate measures, not stages: all 15 personas answered all four questions. Each square is one persona.
Six respondents said the voice is wrong for skeptical clinical and procurement buyers, shifting between B2B language and consumer influencer register and lacking clinical specificity. Not one of the four layers, and it does not affect the scores above or the order to fix them in.
These are 15 simulated buyers. Want 15 real ones?
Test with humansThe first is on your weakest layer, the second on the next, the third on the layer the most buyers had a problem with. Each says what to change on the page and why, with one simulated answer behind it.
Why: Nothing on the page says why saliva at home beats the standard lab panel a clinic already orders. Give turnaround time, number of samples per day, and cost against a lab draw.
5 of 15 raised this
“If a competitor showed me even one number — sensitivity, specificity, correlation to blood cortisol — they'd win by default.”
Why: "Elite programs use Eli" and "Progressive doctors integrate cortisol tracking" name nobody, so the claims read as aspiration. Swap in one named team or clinic, what they measured, and the outcome over a stated period.
5 of 15 raised this
“Earlier burnout detection maybe, but no validation data or numbers given.”
Why: Six citations sit directly under performance claims, implying they validate this device when they are general cortisol research. Head the list plainly and place any Eli-specific data separately.
4 of 15 raised this
“I couldn't tell you the actual assay method or what "independently tested" means since they never cite a study or lab standard for their own product, just a list of unrelated academic papers on cortisol in general.”
These landed. Keep the wording when you edit around it.
The product mechanic is legible — an at-home saliva cortisol test with an app readout…
“They make an at-home saliva test kit called Eli/Hormometer that reads cortisol (with progesterone and testosterone "coming soon"), you scan it with an app and it spits out some readout on your phone about your stress/recovery patterns.”
Why: Buyers already get readiness and recovery data from wearables and the page never says what cortisol adds. Name the specific thing wearables miss, such as a measured awakening response.
5 of 15 raised this
“If a competitor showed me even one number — sensitivity, specificity, correlation to blood cortisol — they'd win by default.”
Why: "Validated accuracy" and "Expand your services beyond what competitors provide" are claims any test vendor could make. Say which assay the device was compared against and how closely results matched.
5 of 15 raised this
“If a competitor showed me even one number — sensitivity, specificity, correlation to blood cortisol — they'd win by default.”
Why: A buyer cannot tell how accurate the saliva test is or who tested it. State the correlation against serum or lab cortisol, the sample size, and the testing body by name.
5 of 15 raised this
“Earlier burnout detection maybe, but no validation data or numbers given.”
Why: No price, per-test cost, or minimum volume appears anywhere, so a clinic or employer cannot judge whether a pilot is worth running. Publish per-test cost and what an organizational pilot includes.
5 of 15 raised this
“Earlier burnout detection maybe, but no validation data or numbers given.”
No specific edits needed here — this layer held up.
Why: Clinical and HR buyers need to know whether the test is a regulated device, where samples are processed, and how employee data is stored. Answer all three in one sentence near the top.
5 of 15 raised this
“The tone is aspirational and a bit breathless — "The future of performance starts inside," "while others continue to guess, you'll have data" — which reads like it's written for a founder pitch deck or an early adopter who gets excited by vision statements, not for someone like me who wants the assay method and a validation number before I'll even take a meeting seriously.”
Why: These read as consumer wellness marketing to clinical and procurement buyers evaluating a diagnostic. Use plain descriptive headings naming the test, the sample type, and the readout.
5 of 15 raised this
“The tone is aspirational and a bit breathless — "The future of performance starts inside," "while others continue to guess, you'll have data" — which reads like it's written for a founder pitch deck or an early adopter who gets excited by vision statements, not for someone like me who wants the assay method and a validation number before I'll even take a meeting seriously.”
Why: A "You're $199 away from free shipping" banner above an enterprise pitch tells procurement this is a direct-to-consumer brand. Keep the organizations page on a single business track with one contact route.
5 of 15 raised this
“The tone is aspirational and a bit breathless — "The future of performance starts inside," "while others continue to guess, you'll have data" — which reads like it's written for a founder pitch deck or an early adopter who gets excited by vision statements, not for someone like me who wants the assay method and a validation number before I'll even take a meeting seriously.”
A deliberately adversarial read of the same answers. Each claim was checked back against what the personas said and dropped if nothing supported it.
The page is legible and unbelievable at the same time — comprehension is not the problem, evidence is.
Three respondents played back saliva cortisol, app readout and the roadmap unaided, yet four rejected the validation claims for lacking method or metric and five could not assess value at all. Clarity of mechanic buys nothing without proof.
A single published accuracy number from any competitor erases this page's entire position.
Five respondents found nothing separating Eli from alternatives, and one stated a rival wins by default on one published metric. The differentiation rests on claims a competitor can out-evidence in one line.
The voice actively disqualifies the page with the buyers it names as targets.
Five respondents said the register reads as a startup pitch deck or DTC wellness brand and is wrong for skeptical clinical and procurement buyers; three read direct-sales CTAs and missing traction as proof the company is not in procurement lanes.
Nothing on the page supports a purchase conversation — the only stated path forward is conditional on data that is absent.
Five respondents withheld any judgment of worth for lack of pricing, cost-per-test or correlation coefficients, and two said they would pilot only on receipt of correlation data. The page cannot progress a deal as written.
The page never justifies the category, so it is arguing against wearables buyers already own and losing.
A respondent noted no evidence cortisol improves on existing wearable data, which compounds the five who saw no comparison to standard blood cortisol labs. The page must win two arguments and makes neither.
Segment lists and trust language read as substitutes for traction and were decoded as such.
Two respondents read category labels as a stand-in for named accounts and rejected them; five cited generic trust claims as a differentiation failure. Proxy signals were treated as evidence of absence.
Respondents said a competitor publishing a single accuracy metric would win the deal
5 of 15
“If a competitor showed me even one number — sensitivity, specificity, correlation to blood cortisol — they'd win by default.”
“"Independently tested" gets said but no data shown - that'd rule it out, not in.”
“I'd need them to show accuracy or correlation data against that before I'd trust the saliva version over it.”
“there's no chart, no side-by-side, no explanation of what cortisol tells me that HRV or resting heart rate doesn't”
Cortisol is never shown to add anything beyond data buyers already get from wearables
1 of 15
“there's no chart, no side-by-side, no explanation of what cortisol tells me that HRV or resting heart rate doesn't”
Value cannot be assessed because no number, case study, or price appears anywhere
5 of 15
“Earlier burnout detection maybe, but no validation data or numbers given.”
“what's the correlation between their saliva readings and actual outcomes (injury, burnout, return-to-play failures), and how does it compare to the blood-cortisol literature they cite from 2014-2025”
“A real case or pilot stat - something like a handful of clients where the cortisol flag preceded a burnout episode by weeks - would make it worth a meeting; without that it stays theoretical.”
'Validated accuracy' and 'independently tested' are asserted with no method, metric, or…
4 of 15
“I couldn't tell you the actual assay method or what "independently tested" means since they never cite a study or lab standard for their own product, just a list of unrelated academic papers on cortisol in general.”
“words like "validated accuracy" and "independently tested" get used without ever saying validated against what, or tested by whom”
“the phrase "independently tested" itself — independent from whom, tested against what reference standard, with what sample size? That's the kind of claim that sounds rigorous but tells me nothing”
“none of those studies are about Eli's device specifically, they're about cortisol as a biomarker in general, so "independently tested" is doing a lot of unproven work”
Category labels stand in for customers, and respondents noticed no account is ever named
2 of 15
“What's missing isn't the "who" or "what" but the "prove it" — no named clinics or teams, just category labels, so I still don't know if anyone like me is actually using this day to day.”
“There's no clinic name, no logo, no case study attached to any of those lines, so I genuinely couldn't tell if I was reading a customer list or a target audience list.”
The product mechanic is legible — an at-home saliva cortisol test with an app readout…
3 of 15 · what worked
“They make an at-home saliva test kit called Eli/Hormometer that reads cortisol (with progesterone and testosterone "coming soon"), you scan it with an app and it spits out some readout on your phone about your stress/recovery patterns.”
“They make an at-home saliva test kit called Eli/Hormometer that scans with an app to track cortisol (and later progesterone/testosterone) rhythms over time - basically a home hormone-monitoring test for stress, sleep, and training recovery.”
The tone reads as a startup pitch deck or DTC wellness brand, not a clinical vendor
5 of 15
“The tone is aspirational and a bit breathless — "The future of performance starts inside," "while others continue to guess, you'll have data" — which reads like it's written for a founder pitch deck or an early adopter who gets excited by vision statements, not for someone like me who wants the assay method and a validation number before I'll even take a meeting seriously.”
“but then it swings into consumer-influencer voice with lines like "The future of performance starts inside" and "while others continue to guess, you'll have data," which reads like ad copy for an individual athlete, not procurement copy”
“The B2B page reads like it was bolted onto a consumer DTC site rather than built for me: lots of confident category-naming ("Hormometer™", "the first instant hormone monitoring platform") and forward-looking roadmap items ("coming soon" for progesterone and testosterone)”
“Tone's marketing-y, not written for a skeptical clinical buyer like me.”
The page signals an early-stage company still undecided between DTC and B2B
3 of 15
“The "For businesses" and "Contact us" CTAs instead of a self-serve buy button tell me they're still in direct-sales mode, probably closing deals one team or clinic at a time”
“They're clearly trying to sell in two directions at once — DTC wellness shoppers (the free shipping banner, the cart) and B2B accounts (teams, clinics, corporate wellness) — which tells me they haven't picked a lane yet”
15 AI-simulated personas matched to your target market. Each answered independently, without seeing your goal, the scoring criteria, or each other’s answers. Attribution is role, industry and company size only.
Every answer on this page was written by an AI model role-playing a buyer profile, scored on Wynter’s B2B Message Layers framework. The personas were sampled in code across role, industry, company size and behavioral traits; the model wrote only the answers. Scores arrive through fixed verdict categories and the counts are computed in our own code, so no number here was written by a model.
The count is how many personas cleared the bar on each question. A yes can be unhesitating or come with reservations; the scorecard counts both as a yes, and this is the only place the difference is shown. Per layer:
These answers are AI-simulated and directional. Validate anything you’re betting on with real buyers, your ICPs.
A detailed, section-by-section message test report from verified B2B professionals who are actually in-market for what you sell.







